December 7, 2017 — Science Translational Medicine has published an article by experts from the Foundation for the National Institutes of Health, the National Institutes of Health, the U.S. Food and Drug Administration (FDA), industry, academia and not-for-profit organizations that outlines a framework for the level of evidence needed to support qualification of biological markers (biomarkers) for use in drug development decision making.
November 30, 2017 — Science has published an article outlining guiding principles for sponsors and supporters of gene drive research agreed upon by 13 organizations thus far, including the Foundation for the National Institutes of Health. Considered an emerging technology still in early research, gene drive can be used to promote the preferential inheritance of a beneficial trait, thereby increasing its prevalence in a population.
July 27, 2017 — The Foundation for the National Institutes of Health (FNIH) is delighted to once again earn the highest, 4-star rating from Charity Navigator, in addition to being named the #1 charity among biomedical research organizations. As America’s largest charity evaluator, Charity Navigator acknowledged the FNIH for demonstrating strong financial health and commitment to accountability and transparency.
June 15, 2017 – The Foundation for the National Institutes of Health (FNIH) has launched a new project to shorten the treatment times of tuberculosis (TB) in drug-sensitive patients through individualized therapy. The $24 million project, “Using Biomarkers to Predict TB Treatment Duration” (PredictTB), is funded in-part by the FNIH through a $13 million donation from the Bill & Melinda Gates Foundation, with management support provided by the National Institute of Allergy and Infectious Diseases (NIAID) and Catalysis Foundation for Health.
June 7, 2017— The White House has announced that Francis Collins, M.D., Ph.D.—an ex-officio member of the Foundation for the National Institutes of Health (FNIH) Board of Directors—will continue to serve in the role of Director of the National Institutes of Health (NIH). The FNIH extends its congratulations to Dr. Collins on remaining in the role that he has maintained for the past eight years.